GenMark Diagnostics to Participate in Upcoming Investor Conferences
13 nov. 2019 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics Reports Third Quarter 2019 Results
06 nov. 2019 16h03 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019
23 oct. 2019 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close...
GenMark Diagnostics Reports Second Quarter 2019 Results
05 août 2019 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
25 juil. 2019 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 25, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019
22 juil. 2019 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
23 mai 2019 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics to Present at the Bank of America Merrill Lynch Health Care Conference
01 mai 2019 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics Reports First Quarter 2019 Results
30 avr. 2019 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics Expands Commercial Team
30 avr. 2019 16h02 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it...